myeloMATCH precision medicine clinical trial leverages next-day genomic testing to quickly match patients with appropriate trials across North America
The dual polymer plates include polypropylene wells for optimal thermal transfer and enhanced reaction efficiency, leading to more accurate and reliable results
Discovery advances research into how diabetes impacts and damages blood vessels
Assay automation from Beckman Coulter Life Sciences and Illumina makes cutting-edge research more accessible to labs
With the help of next-gen protein sequencing tools, researchers have developed a new way to find, trap, and characterize altered protein shapes underlying multiple diseases
Cytovance and Celltheon partner to provide an integrated solution for customers seeking to outsource cell line development through to cGMP manufacturing of mammalian-expressed products
Streamlining the macrodissection annotation process for both primary and metastatic non-small cell lung cancer cases
Bio-Rad adds rapid bispecific antibody prototyping and screening services to its Pioneer Antibody Discovery Platform
Expanding capabilities and streamlining experimental workflows
Dr. Christian Regenbrecht discusses the power of patient-derived tumor organoids and their promising future in clinical practice
Bio-Rad outlines strategic collaborations to enable clinical evidence generation and advance precision oncology
Study aims to improve detection of women at risk of pregnancy complication
This guest editorial outlines how the collaboration between Camena Bioscience and SPT Labtech is driving innovation in the field of DNA synthesis
Sapio Sciences announces new capabilities to highly flexible, no/low code LIMS to support laboratories complying with GMP, 21 CFR 11 and EU Annex 11 standards
Dr. Ana de Oliveira from the Spatial Biology Core at UVA discusses the potential of the field to supercharge research across sectors
Fast, efficient and economical preparation of viable cell suspensions from small tissue samples
Strategic agreement unites best-in-class technology with end-to-end development solutions to optimize therapeutic development process
Providing tools, training, and support for Sapio's lab informatics platform
Learn how researchers used the Orion™ platform from RareCyte to generate spatial insights into tumor microenvironments
Nucleic acids in blood can provide valuable information about cancer, but how can we stabilize them prior to analysis?
From the manufacture and supply of raw materials to risk mitigation and assay development capabilities, learn how Merck is helping IVD developers bring new devices to market
AMSBIO launches new Glucagon-Like Peptide 1 Receptor (GLP-1R) reporter cell line
Discovery of new family of ligase enzymes could revolutionize the production of treatments for cancer
Compact system uses CMOS digital imaging and is compatible with chemiluminescence and fluorescence detection and stain-free technology
